Shopping cart
Your cart empty!
Terms of use dolor sit amet consectetur, adipisicing elit. Recusandae provident ullam aperiam quo ad non corrupti sit vel quam repellat ipsa quod sed, repellendus adipisci, ducimus ea modi odio assumenda.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Do you agree to our terms? Sign up
Hospital stocks are in focus today following the biggest revision in Central Government Health Scheme (CGHS) package rates in 15 years. The new rates, covering nearly 2,000 medical procedures, will come into effect on October 13, 2025.
Analysts estimate the rate revision could lift hospital revenues by around 2.5% and boost EBITDA by up to 10% for companies with significant government exposure.
Shares of Apollo Hospitals, Max Healthcare, Fortis, and Narayana Health have all responded positively, trading higher in early market action.
Market expert Avinash Gorakshakar said the move is a clear positive for the sector:
“Larger players like Apollo, Fortis, Narayana Health, and even smaller ones like Yatharth Hospital will be in the limelight today. Investors should look at this as a long-term portfolio choice. Any dip is a good opportunity to accumulate because Q2 will be stronger than Q1. We are structurally positive on hospital stocks.”
Long-term potential: With rising government reimbursements and steady patient volumes, hospital stocks may deliver sustainable returns.
Short-term trading: Positive sentiment could fuel near-term price gains, especially for companies with higher CGHS exposure.
Dip accumulation: Analysts suggest using market dips as an entry point for long-term investments.
(Disclaimer: The views and recommendations in this article are for informational purposes only. Consult a qualified financial advisor before making investment decisions.)
5
Published: Oct 06, 2025